BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9213055)

  • 1. Collins' law. Prediction of recurrence or cure in childhood medulloblastoma?
    Sure U; Berghorn WJ; Bertalanffy H
    Clin Neurol Neurosurg; 1997 May; 99(2):113-6. PubMed ID: 9213055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of medulloblastoma: violation of Collins' law after two decades.
    Friedberg MH; David O; Adelman LS; Heilman CB
    Surg Neurol; 1997 Jun; 47(6):571-4. PubMed ID: 9167782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival.
    Brown WD; Tavaré CJ; Sobel EL; Gilles FH
    Neurosurgery; 1995 Apr; 36(4):691-7. PubMed ID: 7596498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma: survival and late recurrence after the Collins' risk period.
    Nishio S; Morioka T; Takeshita I; Fukui M
    Neurosurg Rev; 1997; 20(4):245-9. PubMed ID: 9457719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma. Period of risk reviewed.
    Latchaw JP; Hahn JF; Moylan DJ; Humphries R; Mealey J
    Cancer; 1985 Jan; 55(1):186-9. PubMed ID: 3965079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?
    Belza MG; Donaldson SS; Steinberg GK; Cox RS; Cogen PH
    J Neurosurg; 1991 Oct; 75(4):575-82. PubMed ID: 1885975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
    Roldán G; Brasher P; Vecil G; Senger D; Rewcastle B; Cairncross G; Forsyth P; Hamilton M
    Can J Neurol Sci; 2008 May; 35(2):210-5. PubMed ID: 18574936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late recurrence in medulloblastoma.
    King GA; Sagerman RH
    Am J Roentgenol Radium Ther Nucl Med; 1975 Jan; 123(1):7-12. PubMed ID: 1119661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late recurrence of primitive neuroectodermal tumor/medulloblastoma.
    Lefkowitz IB; Packer RJ; Ryan SG; Shah N; Alavi J; Rorke LB; Sutton LN; Schut L
    Cancer; 1988 Aug; 62(4):826-30. PubMed ID: 2840194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.
    Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE
    J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of radiosurgery in the management of recurrent and residual medulloblastoma.
    Patrice SJ; Tarbell NJ; Goumnerova LC; Shrieve DC; Black PM; Loeffler JS
    Pediatr Neurosurg; 1995; 22(4):197-203. PubMed ID: 7619720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma in adulthood: prognostic factors influencing survival and recurrence.
    Aragonés MP; Magallón R; Piqueras C; Ley L; Vaquero J; Bravo G
    Acta Neurochir (Wien); 1994; 127(1-2):65-8. PubMed ID: 7942185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The applicability of Collins' Law to childhood brain tumors and its usefulness as a predictor of survival.
    Brown WD; Tavaré CJ; Sobel EL; Gilles FH
    Neurosurgery; 1995 Jun; 36(6):1093-6. PubMed ID: 7643986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical effects of radiation therapy for primitive gliomas and medulloblastomas: a role for radiosurgery.
    Inoue HK; Nakamura M; Ono N; Kawashima Y; Hirato M; Ohye C
    Stereotact Funct Neurosurg; 1993; 61 Suppl 1():51-8. PubMed ID: 8115756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma.
    Zhang R; Zhou L
    Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma: the Duke University Medical Center experience.
    Hershatter BW; Halperin EC; Cox EB
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1771-7. PubMed ID: 3759529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.
    Sure U; Bertalanffy H; Isenmann S; Brandner S; Berghorn WJ; Seeger W; Aguzzi A
    Acta Neurochir (Wien); 1995; 136(3-4):117-26. PubMed ID: 8748840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
    Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
    J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.